Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C31H37NO7 |
| Molecular Weight | 535.628 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 8 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C\C=C/C1O[C@@]23CC[C@](O1)(C(=O)COC(=O)C4=CC=NC=C4)[C@@]2(C)C[C@H](O)[C@H]5[C@H]3CCC6=CC(=O)CC[C@]56C
InChI
InChIKey=LZHLAFIPUJPCBN-ZTOAAZPKSA-N
InChI=1S/C31H37NO7/c1-4-5-25-38-30-12-13-31(39-25,24(35)18-37-27(36)19-9-14-32-15-10-19)29(30,3)17-23(34)26-22(30)7-6-20-16-21(33)8-11-28(20,26)2/h4-5,9-10,14-16,22-23,25-26,34H,6-8,11-13,17-18H2,1-3H3/b5-4-/t22-,23+,25?,26-,28+,29+,30-,31+/m1/s1
| Molecular Formula | C31H37NO7 |
| Molecular Weight | 535.628 |
| Charge | 0 |
| Count |
|
| Stereochemistry | EPIMERIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 7 / 8 |
| E/Z Centers | 1 |
| Optical Activity | UNSPECIFIED |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7426413
At concentration 10(-9) M nicocortonide inhibited synthesis
of hyaluronic acid by 23%. An inhibition of collagen synthesis was obtained with nicocortonide only at the highest studied concentration: 1 x 10(-4) M. The synthesis of sulphated glycosaminoglycans was inhibited (by 30-
35%) at the highest steroid concentration tested (1 x 10(-5) M).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:28:50 GMT 2025
by
admin
on
Mon Mar 31 18:28:50 GMT 2025
|
| Record UNII |
341BNG318Y
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C521
Created by
admin on Mon Mar 31 18:28:50 GMT 2025 , Edited by admin on Mon Mar 31 18:28:50 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB09234MIG
Created by
admin on Mon Mar 31 18:28:50 GMT 2025 , Edited by admin on Mon Mar 31 18:28:50 GMT 2025
|
PRIMARY | |||
|
100000084170
Created by
admin on Mon Mar 31 18:28:50 GMT 2025 , Edited by admin on Mon Mar 31 18:28:50 GMT 2025
|
PRIMARY | |||
|
341BNG318Y
Created by
admin on Mon Mar 31 18:28:50 GMT 2025 , Edited by admin on Mon Mar 31 18:28:50 GMT 2025
|
PRIMARY | |||
|
DTXSID901024353
Created by
admin on Mon Mar 31 18:28:50 GMT 2025 , Edited by admin on Mon Mar 31 18:28:50 GMT 2025
|
PRIMARY | |||
|
Nicocortonide
Created by
admin on Mon Mar 31 18:28:50 GMT 2025 , Edited by admin on Mon Mar 31 18:28:50 GMT 2025
|
PRIMARY | |||
|
4490
Created by
admin on Mon Mar 31 18:28:50 GMT 2025 , Edited by admin on Mon Mar 31 18:28:50 GMT 2025
|
PRIMARY | |||
|
C84009
Created by
admin on Mon Mar 31 18:28:50 GMT 2025 , Edited by admin on Mon Mar 31 18:28:50 GMT 2025
|
PRIMARY | |||
|
6436148
Created by
admin on Mon Mar 31 18:28:50 GMT 2025 , Edited by admin on Mon Mar 31 18:28:50 GMT 2025
|
PRIMARY | |||
|
65415-41-0
Created by
admin on Mon Mar 31 18:28:50 GMT 2025 , Edited by admin on Mon Mar 31 18:28:50 GMT 2025
|
PRIMARY | |||
|
265-754-7
Created by
admin on Mon Mar 31 18:28:50 GMT 2025 , Edited by admin on Mon Mar 31 18:28:50 GMT 2025
|
PRIMARY | |||
|
CHEMBL2106447
Created by
admin on Mon Mar 31 18:28:50 GMT 2025 , Edited by admin on Mon Mar 31 18:28:50 GMT 2025
|
PRIMARY | |||
|
C027263
Created by
admin on Mon Mar 31 18:28:50 GMT 2025 , Edited by admin on Mon Mar 31 18:28:50 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |